294 related articles for article (PubMed ID: 33781552)
1. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
Xu M; Li H; Bai Y; He J; Chen R; An N; Li Y; Dong Y
Am J Med Sci; 2021 May; 361(5):624-634. PubMed ID: 33781552
[TBL] [Abstract][Full Text] [Related]
2. Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease.
Kawakami K; Takeshita A; Furushima K; Miyajima M; Hatamura I; Kuro-O M; Furuta Y; Sakaguchi K
Sci Rep; 2017 Jan; 7():40534. PubMed ID: 28094278
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
4. Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Drüeke TB
Kidney Int; 2010 Dec; 78(11):1057-60. PubMed ID: 21076444
[TBL] [Abstract][Full Text] [Related]
5. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
Arcidiacono MV; Yang J; Fernandez E; Dusso A
Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
8. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
[TBL] [Abstract][Full Text] [Related]
10. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
Komaba H
Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
[TBL] [Abstract][Full Text] [Related]
11. The regulation of FGF23 under physiological and pathophysiological conditions.
Rausch S; Föller M
Pflugers Arch; 2022 Mar; 474(3):281-292. PubMed ID: 35084563
[TBL] [Abstract][Full Text] [Related]
12. The role of FGF23 in CKD--with or without Klotho.
Komaba H; Fukagawa M
Nat Rev Nephrol; 2012 Jun; 8(8):484-90. PubMed ID: 22714041
[TBL] [Abstract][Full Text] [Related]
13. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.
Krajisnik T; Björklund P; Marsell R; Ljunggren O; Akerström G; Jonsson KB; Westin G; Larsson TE
J Endocrinol; 2007 Oct; 195(1):125-31. PubMed ID: 17911404
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.
Olauson H; Lindberg K; Amin R; Sato T; Jia T; Goetz R; Mohammadi M; Andersson G; Lanske B; Larsson TE
PLoS Genet; 2013; 9(12):e1003975. PubMed ID: 24348262
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
Naveh-Many T; Volovelsky O
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570711
[TBL] [Abstract][Full Text] [Related]
17. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
Quarles LD
Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
[TBL] [Abstract][Full Text] [Related]
18. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
19. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
[TBL] [Abstract][Full Text] [Related]
20. FGF23 and the parathyroid glands.
Silver J; Naveh-Many T
Pediatr Nephrol; 2010 Nov; 25(11):2241-5. PubMed ID: 20526631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]